Evidence map›Paper›PMID 38363212›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2024

The gut microbiome as a modulator of arterial function and age-related arterial dysfunction.

Abigail G Longtine, Nathan T Greenberg, Yara Bernaldo de Quirós, Vienna E Brunt

Abstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Abigail G LongtineDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.ORCID 0000-0001-7905-8341
Nathan T GreenbergDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.ORCID 0000-0001-5174-3195
Yara Bernaldo de QuirósDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.
Vienna E BruntDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.ORCID 0000-0002-1941-7936
University of Colorado Boulder · USUniversidad de Las Palmas de Gran Canaria · ES

Funding

Translational Studies of the Short-Chain Fatty Acid Acetate for Improving Age-Associated Arterial DysfunctionR00HL151818 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BRUNT, VIENNA E · 2022 to 2024
$747k
Translational Studies of the Short-Chain Fatty Acid Acetate for Improving Age-Associated Arterial DysfunctionK99HL151818 · NHLBI · UNIVERSITY OF COLORADO · PI BRUNT, VIENNA E · 2021 to 2022
$349k
Role of the human gut microbiome in modulating age-associated aortic stiffening.F31HL164004 · NHLBI · UNIVERSITY OF COLORADO · PI GREENBERG, NATHAN THOMAS · 2022 to 2023
$70k
Role of the human gut microbiome and related metabolites for causally mediating vascular endothelial functionF31HL160173 · NHLBI · UNIVERSITY OF COLORADO · PI LONGTINE, ABIGAIL GRACE · 2022 to 2023
$65k
NHLBI NIH HHS F31 HL160173NHLBI NIH HHS F31 HL164004NHLBI NIH HHS K99 HL151818NHLBI NIH HHS R00 HL151818
6 · The paper itself

Abstract

The arterial system is integral to the proper function of all other organs and tissues. Arterial function is impaired with aging, and arterial dysfunction contributes to the development of numerous age-related diseases, including cardiovascular diseases. The gut microbiome has emerged as an important regulator of both normal host physiological function and impairments in function with aging. The purpose of this review is to summarize more recently published literature demonstrating the role of the gut microbiome in supporting normal arterial development and function and in modulating arterial dysfunction with aging in the absence of overt disease. The gut microbiome can be altered due to a variety of exposures, including physiological aging processes. We explore mechanisms by which the gut microbiome may contribute to age-related arterial dysfunction, with a focus on changes in various gut microbiome-related compounds in circulation. In addition, we discuss how modulating circulating levels of these compounds may be a viable therapeutic approach for improving artery function with aging. Finally, we identify and discuss various experimental considerations and research gaps/areas of future research.

Indexed as

Cardiovascular DiseasesGastrointestinal MicrobiomeArteriesHumansarterial stiffnesscardiovascular healthendothelial functiongut-derived metabolitesgut-targeted therapies

Identifiers

PMID38363212
PMCPMC11279790
OpenAlexW4391884882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.